Introduction
============

*Helicobacter pylori* (*H. pylori*) is a gram-negative bacterium that colonizes the stomach. The global prevalence rate of *H. pylori* infection is as high as 90% in some developing countries ([@R6]) and an estimated 20--30% of infected individuals subsequently develop disease, including peptic ulcers, gastric cancer, or mucosal-associated lymphoid tissue lymphomas ([@R2]). The risk of different clinical outcome expression of *H. pylori* infection is believed to rely on interactions between host genetic factors and bacterial factors ([@R1]). Toll-like receptors (TLRs) are pathogen-associated molecular pattern receptors, mediators of innate immunity that are essential for the recognition of microbial antigens by the immune cells. The gastric epithelial cell signaling response to *H. pylori* infection. TLR1, TLR2, TLR4, TLR5, TLR6, and TLR10 on the cell surface or *TLR9* in intracellular vesicles interact with *H. pylori* virulence factor causes the host immune responses and lead sing to the activation of NF-kB and subsequent proinflammatory cytokine release ([@R16]). The TLRs polymorphisms can confer host susceptibility to *H. pylori* infection and likely influence association with *H. pylori*-related diseases by modulating the release of proinflammatory or antiproinflammatory cytokines, which underlie gastric inflammation and the immune response to *H. pylori*. *TLR1* polymorphisms have been reported to confer a high risk of *H. pylori* infection. The *TLR1 *rs4833095** CT genotype or the T allele has been shown to be correlated with a decreased risk of *H. pylori* infection and reduced risks of chronic atrophic gastritis and intestinal metaplasia in Chinese patients ([@R23]). The polymorphisms of TLR2 are associated with susceptibility to gastric cancer among various ethnic groups such as in Japanese, Chinese, and Caucasian populations. TLR4 are more frequent in relation to gastritis, and gastric cancer has been found worldwide including Europe, Asia, and America ([@R9] [@R8] [@R3], [@R4]). Especially in the Chinese population, [@R3], [@R4] reported that six TLR4 polymorphisms (*rs11536889, rs10759931, rs1927911, rs10116253, rs10759932*, and *rs2149356*) were associated significantly with gastric cancer. However, there is no association between TLR4 polymorphisms and *H. pylori* related gastritisc diseases in some studied populations such as in an ethnic Kashmiri population ([@R14]) or a weak association revealed very rare in Japanese population ([@R18]; [@R7]). Polymorphisms in *TLR10* have a known direct association with *H. pylori* susceptibility in European and Chinese populations. The *TLR10 *rs10004195**, T allele decreased the risk of chronic atrophic gastritis and haplotype TT had a protective effect on *H. pylori* infection or precancerous gastric lesions ([@R19]). [@R15] found that individuals with the **rs10004195** T allele were not protected against the development of GC in Malaysian patients whereas haplotype AA of *rs10004195* was associated with an increase in GC irrespective of *H. pylori* infection. Among different populations, the association between the TLR(s) polymorphism and *H. pylori* infection-related diseases is inconsistent, but the impact of TLR polymorphisms on the *H. pylori*-related pathologic process has not yet been established in Thailand patients. The investigation of polymorphisms in Thai populations could provide novel insights into targeted treatment in genetically susceptible individuals and improve the prevention of *H. pylori*-related GC. Therefore, we hypothesized that specific genetic polymorphisms in TLR1, TLR2, TLR4, and TLR10 genes are likely associated with *H. pylori*-related gastric diseases and outcomes by affecting the *H. pylori* susceptibility of the hosts. It can be expected that the association of genetic polymorphisms in the host and clinical outcomes of *H. pylori*-related gastritis will be uncovered with advancing technologies and, in the near future, there is every prospect of defining full genetic risk profiles.

Patients and methods
====================

Patients
--------

Four hundred patients undergoing esophagogastroduodenoscopy for investigation of chronic abdominal pain participated in this study from December 2014 to March 2016. The following exclusion criteria were applied: previous *H. pylori* eradication treatment in the previous 2 months, significant medical illnesses, history of previous gastric surgery, and the use of antimicrobials or gastrointestinal medications such as proton-pump inhibitor or bismuth compounds within the previous 2 months. The study was carried out in accordance with good clinical practice and the guidelines of the Declaration of Helsinki. All patients provided written informed consent and the study protocol was approved by the Ethics Committee for Research Involving Human Subjects, Suranaree University of Technology (EC-58-58 and EC-58-59).

Diagnosis of *H. pylori-*associated gastritis
---------------------------------------------

A diagnosis of *H. Pylori-*associated gastritis was made if *H. pylori* were seen on histopathological examination and the rapid urease test was positive. Finally, we proved bacterial infection by PCR.

Biopsy specimens
----------------

The esophagogastroduodenoscopy procedures were performed using an upper GI video endoscope (Olympus EVIS EXERA III, CV-190, Japan). The entire stomach was examined first by conventional endoscopy and then biopsies were performed using the 'Site Specific Biopsy' technique ([@R20], [@R21]). Gastric tissue specimens for histological analysis were sent to the pathologist. The hematoxylin and eosin stain, and Giemsa stain were used for the identification of *H. pylori*.

DNA preparation
---------------

Genomic DNA was extracted from formalin-fixed, paraffin-embedded tissue of 400 gastric patients using the QIAamp DNA formalin-fixed, paraffin-embedded tissue kit (Qiagen, Duesseldorf, Germany). The DNA extraction was performed according to the manufacturer's instructions. Briefly, deparaffinize the paraffin-embedded tissues in xylene and hydrate in 100% ethanol.

Single-nucleotide polymorphisms selection and genotyping
--------------------------------------------------------

Four common single-nucleotide polymorphisms (SNPs) in TLR1, TLR2 TLR4, and TLR10 genes have been reported with functional effects or association with gastric cancer. *TLR1 *rs4833095** (C\>T), *TLR2 *rs3804099** (T\>C), **rs3804100** (T\>C), *TLR4 rs10759932* (T\>C), and *TLR10 *rs10004195** (T\>A) were selected according to the SNP database of the National Center for Biotechnology Information. The genotype of TLR(s) polymorphism was determined by TagMan allelic discrimination using a predesigned Custom TagMan SNP Genotyping Assay by real-time PCR (Roche diagnostics, Neuilly sur Seine, France). Forward and reverse primers were used along with wild-type probe VIC and probes FAM used for the variant allele. Primers and probes were supplied by Applied Biosystems (Foster city, California, USA). The real-time PCR system was used according to the manufacturer's instructions (LightCycler 480 II instrument; Roche Diagnostics, Neuilly sur Seine, France). Briefly, the PCR conditions were as follows: 95°C for 10 min, 55 cycles of 95°C for 15 s, and 60°C for 1 min. The success rate of genotyping for each SNP was more than 94%. Negative controls and duplicate samples were used to check the accuracy of genotyping and initially analyzed using LightCycler 480 Software 1.5 (Roche Applied Science, Mannheim, Germany).

Statistical analysis
--------------------

The patients' demographic data, patients' symptom, endoscopic findings, and TLRs were examined through univariate analysis. Backward stepwise procedures were used to carry out the multivariate analysis; the final model included only those variables that were found to be statistically significant in the univariate analysis. The associations were expressed as odds ratios (OR) with their confidence intervals (95% CI). The data were analyzed using the SPSS software (IBM SPSS Statistics for Windows, version 20, Armonk, New York, USA). Significance was set at *P* less than 0.05.

Results
=======

Characteristics of study population
-----------------------------------

A total of 400 patients, 204 *H. Pylori-*positive cases and 196 *H. Pylori-*negative cases, were matched by sex, age, patient symptoms, and endoscopic findings (Table [1](#T1){ref-type="table"}). In the Thai population, the mean age was 46±1.5 years (18--70 years) for the *H. Pylori-*infected patients and 42±2.5 years (19--68 years) for the *H. Pylori-*infected patients. Most of the gastritis was chronic dyspepsia (74.3 or 71.8%). Nonulcer gastritis/duodinitis was found to be the predominant endoscopic finding identified, 140 in *H. Pylori-*positive cases and 128 in *H. Pylori-*negative cases, but there were no statistically significant differences in the distribution of sex, age, patient symptoms, and endoscopic findings between *H. Pylori-*infected patients and uninfected patients.
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Association between demographic data, patients' symptoms, and endoscopic findings *H. pylori* infection (univariate analysis)
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Association between toll-like receptors polymorphism and *H. pylori* infection
------------------------------------------------------------------------------

Figure [1](#F1){ref-type="fig"} presents the genotype distribution of all SNPs. Among all patients, the distribution of *TLR2 *rs3804099**, *rs3804100*, and *TLR4 rs10759932* showed a higher frequency of the TT genotype than the TC/TT genotypes, whereas *TLR1 *rs4833095** showed a lower frequency of the CC genotype than the CT/TT genotypes. Similarly, the *TLR10 *rs10004195** AA genotype showed a lower frequency than the CT/TT genotypes. Genotypes of the TLR1, TLR2, TLR4, and TLR10 polymorphisms were differentiated using the TagMan SNP genotyping assay by real-time PCR (Fig. [2](#F2){ref-type="fig"}). We evaluated the association between TLR1, TLR2, TLR4, and TLR10 polymorphisms and the risk of *H. pylori* infection. Interestingly, *TLR1 *rs4833095** showed a significant association with *H. pylori* infection (*P*=0.01); frequencies of CC, CT, and TT genotypes were 60, 2, and 38% in *H. pylori*-positive patients in contrast to 7, 93, and 0% in *H. pylori*-negative patients, respectively. *TLR10 *rs10004195** also showed a significant association with *H. pylori* infection (*P*=0.04); frequencies of AA, AT, and TT genotypes were 29, 5, and 66% in *H. pylori*-positive patients and 1, 3, and 26% in *H. pylori*-negative patients, respectively (Table [2](#T2){ref-type="table"}). In the multivariate analysis model, we detected a significantly increased risk of TLR1 *rs4833095* for *H. pylori* infection with the homozygous CC (OR=1.76, 95% CI=1.84--2.15, *P*=0.01). In addition, compared with *TLR10 rs1004195*, we found that the AA genotype led to a significantly increased risk for *H. pylori*-related infection (OR=1.81, 95% CI=1.18--3.26, *P*=0.02) as shown in Table [3](#T3){ref-type="table"}.
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Association between toll-like receptors genotypes and *H. pylori* infection (univariate analysis)
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Predictive value of toll-like receptors for *H. pylori* infection (multivariate analysis)
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Discussion
==========

This study indicated that *TLR1* *rs4833095* and *TLR10* *rs10004195* were associated with *H. pylori* susceptibility in the Thai population. The *TLR1 rs4803395*, C allele was associated with a significantly increased risk for *H. pylori* infection and the *TLR10 *rs10004195**, A allele conferred a high risk of *H. pylori* infection. Furthermore, the CT genotype or the T allele of *TLR1 rs4803395* conferred protection against *H. pylori* infection, whereas the AT genotype or the T allele of *TLR10 *rs10004195** exerted a protective effect on *H. pylori* infection; however, this was not statistically significant (Table [2](#T2){ref-type="table"}). This finding further supports that TLR1 and TLR10 genetic polymorphisms have an impact on the susceptibility to *H. pylori* infection by the modulation of the signaling pathway in the inflammatory response initiated by interactions between the host receptor and bacterial antigens such as lipopolysaccharides. The different outcomes of the inflammatory response, including the development of precancerous lesions of gastric mucosa, are likely mediated by the downstream expression of the key inflammatory cytokines, especially interleukin-1β (IL-1β), IL-1α, IL-6, IL-8, IL-10, tumor necrosis factor-α, and interferons, which have been shown to be varied among different genetic polymorphisms of *TLR* genes. In line with this hypothesis, some SNPs of these genes were reported to be closely associated with susceptibility to gastric cancer in the Chinese population ([@R19]). *H. pylori* infection plays an important role in gastric cancer, but there is a low incidence of gastric cancer in the Thai population ([@R22]). In this study, the TLR1 and TLR10 genotype distributions were identified and variant genotypes (heterozygous and homozygous) were predominantly found in Thai patients. The percentage of CC alleles was 65% in *TLR1 *rs4833095** and the frequency of the A allele was 80% in *TLR10 rs10001495* (Fig. [1](#F1){ref-type="fig"}). Variant genotypes of *TLR1 *rs4833095** and *TLR10 rs10001495* in Thai population may suggest that these genotypes of *TLR1 *rs4833095** and *TLR10 rs10001495* in Thai population can impair signaling to promote the *H. pylori* infection through mediating host--cell interactions. Therefore, some SNPs of *TLR1* and *TLR10* were proposed to play a role in modifying a risk for the development of gastric cancer or confer a protective effect for certain human cancers including gastric cancer in Thai patients, resulting in the so-called phenomenon 'Thailand enigma'. This study also allows the detection of the SNPs of *TLR2 *rs3804099*, *rs3804100**, and *TLR4 rs10759932* and shows a pattern allelic distribution of these SNPs in Thai patients. Although the polymorphism of *TLR2 *rs3804099** was shown to be associated with susceptibility to gastric cancer in the Chinese population ([@R24]) and *TLR2 *rs3804100** was reported to be commonly associated with an increased risk of *H. pylori* infection-related gastric cancer ([@R3], [@R4]), the actual distribution of each genotype-related disease is unclear. The *TLR4 rs10759932*, C allele was shown to be associated with a significantly decreased risk of *H. pylori* infection ([@R3], [@R4]), but there was no association between *TLR4 rs10759932* and *H. pylori* infection in Thai patients. *TLR4 rs10759932* might not play a direct role in the susceptibility to *H. pylori* infection or there are some other alternative SNPs located in the TLR4 gene that contribute toward *H. pylori*-related gastric disease as an analogous list for the TLR4 gene polymorphisms with the potential for oncogenomic studies ([@R11], [@R11]). Similarly, it was found that TLR2 and TLR5, but not TLR4, are required for *H. pylori*-induced NF-kB activation and chemokine expression by epithelial cells ([@R17]). In addition, our recent studies in genetic polymorphism in another pathway such as *MDM2* in the Thai population showed an association with *H. pylori* infection ([@R20], [@R21]) and the association of *MDM2* with more severe inflammation in *H. pylori*-associated gastritis ([@R21], [@R21]). These could provide the supportive evidences that the outcome of the infection mainly depends on the immune response of the host.

Conclusion
----------

Through *TLR1, TLR2, TLR4*, and *TLR10* polymorphism analysis by a prospective cross-sectional study in Thailand, it was found that the *TLR1* (*rs4833095*)-C allele and the *TLR10* (*rs10004195*)-A allele are *H. pylori* infection-susceptible TLRs polymorphisms in the Thai population. The different genotypes of the TLRs polymorphism indicated that the outcome of *H. pylori* infection depends on the immune status of the host. However, larger multicenter studies are needed with higher *H. pylori*-positive cases to test this hypothesis. Further evaluation of TLR polymorphisms associated with gastric cancer could provide an understanding of the underlying factors attributable to the clinical consequences of *H. pylori* infection.

The authors would like to acknowledge a grant from SUT Research and Development Fund.

Conflicts of interest
=====================

There are no conflicts of interest.
